达芦那韦药物全球专利布局与研发态势分析
|
|
郑丽丽,赵亚娟,吕璐成,赵萍,魏雪梅
|
Analysis of Patents Related to Clinical Trial Drugs of COVID-19 -Darunavir
|
|
Lili Zheng,Yajuan Zhao,Lucheng Lyu,Ping Zhao,Xuemei Wei
|
|
| 表4 印度公司达芦那韦相关专利国家/地区布局趋势 |
| |
|
| 年度 | 韩国 | 欧洲 | 日本 | DE | WO | 澳大利亚 | 加拿大 | 印度 | | 2007 | 0 | 25 | 18 | 0 | 18 | 0 | 4 | 1 | | 2008 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 2009 | 0 | 12 | 5 | 0 | 12 | 0 | 1 | 1 | | 2010 | 10 | 38 | 11 | 0 | 39 | 1 | 18 | 0 | | 2011 | 0 | 1 | 0 | 0 | 4 | 0 | 1 | 0 | | 2012 | 0 | 8 | 0 | 3 | 10 | 0 | 1 | 2 | | 2013 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | | 2014 | 0 | 3 | 0 | 0 | 2 | 0 | 0 | 1 | | 2015 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | | 2016 | 0 | 6 | 0 | 0 | 6 | 0 | 0 | 3 | | 2017 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 2018 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 合计 | 10 | 94 | 34 | 3 | 92 | 1 | 26 | 10 |
|
|
|